Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
2.030
0.00 (0.00%)
Sep 5, 2025, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 28.07 billion as of September 5, 2025. Its market cap has increased by 8.86% in one year.
Market Cap
28.07B
Enterprise Value
27.31B
Revenue
5.29B
Ranking
n/a
PE Ratio
2,889.70
Stock Price
2.03
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 28.07B, an increase of 988.71%. That is a compound annual growth rate of 10.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 28.07B | -13.47% |
Dec 31, 2024 | 32.44B | 25.81% |
Dec 29, 2023 | 25.79B | -15.45% |
Dec 30, 2022 | 30.50B | -28.80% |
Dec 31, 2021 | 42.84B | 221.38% |
Dec 31, 2020 | 13.33B | -28.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 482.35B |
WuXi AppTec | 313.22B |
Shenzhen Mindray Bio-Medical Electronics | 287.79B |
Sichuan Biokin Pharmaceutical | 155.60B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
Aier Eye Hospital Group | 120.10B |
Shanghai United Imaging Healthcare | 116.97B |
Yunnan Baiyao Group Co.,Ltd | 105.81B |